| Date | Title | Description |
| 12.02.2026 | Inside Wealth Family Office 15: Most active investment firms of the ultra-wealthy | CNBC releases its inaugural Inside Wealth Family Office 15 list, ranking the most active large U.S. family offices by disclosed deal activity.
Eric Schmidt’s family office, Hillspire, made 15 investments in 2025, most of them in artificial ... |
| 29.01.2026 | CB Insights Report: Digital Health Funding Hits $22.3B as 14 New Unicorns Emerge | What You Should Know
The Rebound: According to the new State of Digital Health 2025 report from CB Insights, digital health funding rose 19% YoY to $22.3B in 2025, driven by fewer, larger checks—average deal size jumped 29% to $20.3M.
The C... |
| 09.01.2026 | Eli Lilly Taps Chai Discovery’s Frontier AI to Design ‘Computer-Aided’ Biologics | What You Should Know
– Eli Lilly and Company has entered a strategic collaboration with Chai Discovery to deploy frontier AI for the design of novel biologic therapeutics.
– The partnership includes the development of an exclusive, purpose-... |
| 02.01.2026 | Куда столько миллионов? За какие идеи стартапы получали инвестиции в 2025 году | 2025 год стал звездным для юных и амбициозных компаний. В стартапы, созданные буквально парочкой энтузиастов, вкладывались десятки и даже сотни миллионов долларов. Неудивительно, что в гонке за финансирование тысячи компаний пытаются выдели... |
| 23.12.2025 | Chai Discovery: $130 Million Series B At $1.3 Billion Valuation Raised To Advance AI-Driven Molecular Design | Chai Discovery, a San Francisco-based AI company focused on predicting and reprogramming biochemical molecule interactions, has raised a $130 million Series B financing round co-led by Oak HC/FT and General Catalyst, valuing the company at ... |
| 17.12.2025 | AI Propels Drug Discovery: Chai Discovery Secures $130M, Valued at $1.3B | AI biotech firm Chai Discovery secured $130M in new funding. This pushes its valuation to $1.3 billion. Its AI model, Chai-2, is a game-changer. It rapidly designs novel molecules and full-length antibodies. The model targets previously &qu... |
| 15.12.2025 | OpenAI-Backed Chai Discovery Raises $130M to Tackle “Undruggable” Targets with Generative AI | What You Should Know:
– Chai Discovery has secured a $130M Series B financing round, propelling its valuation to $1.3 billion just months after emerging from stealth.
– Co-led by Oak HC/FT and General Catalyst, the funding validates Chai’s ... |
| 15.12.2025 | ИИ вместо пробирок: Chai Discovery привлек $130 млн на цифровой дизайн молекул | Американский биотехнологический стартап Chai Discovery, работающий в сфере разработки лекарств с использованием искусственного интеллекта и поддерживаемый OpenAI, привлек $130 млн (более 10 млрд руб.) в новом раунде финансирования. Оценка к... |
| 15.12.2025 | AI medical research startup Chai Discovery raises $130M in funding
Send us a News Tip
EXTRACT THE SIGNAL FROM THE NOISE
Cookies | Chai Discovery Inc., a startup using artificial intelligence to accelerate drug development, today announced that it has closed a $130 million funding round led by Oak HC/FT and General Catalyst.
The two investment firms were joined by more... |
| 15.12.2025 | This Startup Backed By OpenAI and Jobs Family Is the Latest A.I. Drug Discovery Unicorn | Josh Meier, CEO of Chai Discovery, said his startup’s models are improving at a rapid rate. Courtesy Chai Discovery
Chai Discovery, a San Francisco-based startup backed by OpenAI, is the latest drug discovery company to benefit from a flurr... |
| 15.12.2025 | Chai Discovery Raises $130M in Series B Funding | Chai Discovery, a San Francisco, CA-based AI company that predicts and reprograms the interactions between biochemical molecules, raised $130M in Series B funding, at $1.3 Billion valuation.
The round was led by Oak HC/FT and General Cataly... |
| 21.10.2025 | AI-driven drugmakers fuel wave of cross-border deals in China | This year, cross-border deals in China’s innovative drug sector have accelerated, with artificial intelligence-driven firms emerging as key players. Syneron, Helixon, and XtalPi illustrate the trend, together closing business development (B... |
| 19.09.2025 | Adaptyv leaves the beta phase following its $8m seed round |
Epalinges-based Adaptyv Bio is on the mission to accelerate the design process for proteins, which today remains a long, very tedious, and expensive task as labs and companies lack the automation and data integration to perform repeatable,... |
| 07.08.2025 | Chai Discovery raises $70M to build molecular discovery foundation AI models
Send us a News Tip
EXTRACT THE SIGNAL FROM THE NOISE
Cookies | Chai Discovery, a company that builds frontier artificial intelligence models to predict and reprogram interactions between biochemical molecules, today announced it has raised $70 million to continue its mission to accelerate how scientist... |
| 06.08.2025 | Chai Discovery Raises $70M in Series A Funding | Chai Discovery, a San Francisco, CA-based AI company that predicts and reprograms the interactions between biochemical molecules to accelerate life-changing therapeutics, raised $70m in Series A financing.
The round was led by Menlo Venture... |
| 01.07.2025 | The AI Revolution in Drug Discovery: A New Era of Innovation | The landscape of drug discovery is undergoing a seismic shift. Two companies, XtalPi and Chai Discovery, are at the forefront of this transformation. They are harnessing the power of artificial intelligence (AI) to redefine how we approach ... |
| 01.07.2025 | The Future of Vaccines and Antibodies: A New Era in Medicine | In the world of medicine, innovation is the lifeblood that keeps the industry vibrant. Two recent breakthroughs showcase the power of science and technology in fighting diseases: Moderna's promising flu vaccine and Chai Discovery's revoluti... |
| 30.06.2025 | Docusign Strengthens Its Growth Ambitions in Europe With the Appointment of Stéphane Barberet as Gvp & General Manager for Emea | Docusign, the Intelligent Agreement Management company, announces the appointment of Stéphane Barberet as Group Vice President & General Manager for EMEA. By bringing aboard proven leadership with extensive enterprise SaaS experience, D... |
| 30.06.2025 | Chai Discovery Unveils Chai-2 Breakthrough, Achieving Fully De Novo Antibody Design With AI | Chai Discovery, which builds frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules, announced a breakthrough in the de novo design of antibodies. The company’s latest model, Chai-2, demonst... |
| 12.11.2024 | Northflank Secures $22.3 Million to Simplify Developer Workloads | In the fast-paced world of technology, developers often find themselves wrestling with complex infrastructure instead of focusing on what they do best: writing code. Northflank, a London-based startup, aims to change that narrative. With a ... |
| 11.11.2024 | Northflank: Developer Workload Platform Company Secures $22.3 Million | Northflank, a developer workload platform, announced $22.3 million in new funding, including a $16 million Series A led by Bain Capital Ventures (BCV) and a $6.3 million seed led by Vertex Ventures US. Additional investors participating in ... |
| 11.11.2024 | Exclusive: Northflank scores $22.3 million to make cloud infrastructure less of a nightmare for developers | Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More
Northflank, a London-based cloud deployment platform, announced $22.3 million in new funding today to help compan... |
| - | Chai Discovery | “Building AI foundation models to predict and reprogram the interactions between biochemical molecules, the fundamental building blocks of life. ” |
| - | Chai Discovery | “Building frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules.” |
